In a randomized trial involving 5,887 pancreatic cancer patients, implementing best practices, including optimal chemotherapy and supportive care, showed no improvement in one-year survival or quality of life. Notably, a substantial number of patients did not receive tumor-directed treatment, emphasizing the necessity for more personalized therapeutic approaches in pancreatic cancer care.
Journal Article by Mackay TM, Latenstein AEJ (…) Besselink MG et 37 al. in JAMA Surg